About 4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide
4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide (PubChem CID 67137763) has the molecular formula C30H36BrFN4O5
and a molecular weight of 631.54 g/mol. Its IUPAC name is 4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide.
Molecular Properties
| Compound Name | 4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide |
| PubChem CID | 67137763 |
| Molecular Formula | C30H36BrFN4O5 |
| Molecular Weight | 631.54 g/mol |
| Exact Mass | 630.19 |
| IUPAC Name | 4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide |
| SMILES | Br.[H]/N=C1/c2c(cc(OC)c(OC)c2F)CN1CC(=O)c1cc(OCCCC#N)c(OCCCC#N)c(C(C)(C)C)c1 |
| InChI | InChI=1S/C30H35FN4O5.BrH/c1-30(2,3)21-14-19(15-24(39-12-8-6-10-32)27(21)40-13-9-7-11-33)22(36)18-35-17-20-16-23(37-4)28(38-5)26(31)25(20)29(35)34;/h14-16,34H,6-9,12-13,17-18H2,1-5H3;1H/b34-29-; |
| InChIKey | MFJFHANTGBBKKX-UPWYNGQOSA-N |
| XLogP | 6.11 |
| TPSA | 128.66 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 631.54 |
| LogP ≤ 5 | 6.11 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Analyze 4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide?
The IUPAC name of 4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide (CID 67137763) is 4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide.
What is the SMILES notation for 4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide?
The canonical SMILES for 4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide is Br.[H]/N=C1/c2c(cc(OC)c(OC)c2F)CN1CC(=O)c1cc(OCCCC#N)c(OCCCC#N)c(C(C)(C)C)c1.
What is the InChIKey of 4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide?
The InChIKey is MFJFHANTGBBKKX-UPWYNGQOSA-N. The full InChI is InChI=1S/C30H35FN4O5.BrH/c1-30(2,3)21-14-19(15-24(39-12-8-6-10-32)27(21)40-13-9-7-11-33)22(36)18-35-17-20-16-23(37-4)28(38-5)26(31)25(20)29(35)34;/h14-16,34H,6-9,12-13,17-18H2,1-5H3;1H/b34-29-;.
What are the key properties of 4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide?
4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide has a molecular weight of 631.54 g/mol, XLogP of 6.11, 13 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[3-tert-butyl-2-(3-cyanopropoxy)-5-[2-(4-fluoro-3-imino-5,6-dimethoxy-1H-isoindol-2-yl)acetyl]phenoxy]butanenitrile;hydrobromide is sourced from PubChem (CID 67137763), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).